Taiko Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3,332	4,256	4,532	5,484	3,105	5,796
Short-Term Investments	500	-	-	-	400	302
Cash & Short-Term Investments	3,832	4,256	4,532	5,484	3,505	6,098
Cash Growth	-18.00%	-6.09%	-17.36%	56.46%	-42.52%	23.34%
Receivables	1,535	2,450	2,428	1,985	1,798	4,056
Inventory	1,930	1,618	1,675	1,373	1,952	3,205
Other Current Assets	172	109	126	267	301	424
Total Current Assets	7,469	8,433	8,761	9,109	7,556	13,783
Property, Plant & Equipment	3,331	3,312	3,271	3,581	6,397	7,113
Long-Term Investments	492	269	747	526	867	1,338
Other Intangible Assets	32	34	27	1	222	299
Long-Term Deferred Tax Assets	-	221	105	1	2	-
Other Long-Term Assets	1	1	3	2	2	2
Total Assets	11,325	12,270	12,914	13,220	15,046	22,535
Accounts Payable	399	422	338	375	274	309
Accrued Expenses	59	247	176	75	23	149
Current Portion of Long-Term Debt	421	792	1,206	1,206	1,039	923
Current Portion of Leases	-	14	18	27	29	36
Current Income Taxes Payable	701	683	728	782	571	1,282
Other Current Liabilities	225	351	389	581	857	1,621
Total Current Liabilities	1,805	2,509	2,855	3,046	2,793	4,320
Long-Term Debt	-	-	792	1,999	2,720	3,760
Long-Term Leases	-	10	11	22	21	54
Pension & Post-Retirement Benefits	624	623	655	624	659	805
Long-Term Deferred Tax Liabilities	-	6	20	188	125	104
Other Long-Term Liabilities	633	605	618	603	685	686
Total Liabilities	3,062	3,753	4,951	6,482	7,003	9,729
Common Stock	10	10	10	2,267	1,201	1,201
Additional Paid-In Capital	4,978	4,978	4,997	2,689	1,642	1,648
Retained Earnings	3,189	3,450	2,526	1,628	5,239	10,134
Treasury Stock	-237	-237	-273	-300	-348	-388
Comprehensive Income & Other	323	316	703	454	309	211
Shareholders' Equity	8,263	8,517	7,963	6,738	8,043	12,806
Total Liabilities & Equity	11,325	12,270	12,914	13,220	15,046	22,535
Total Debt	421	816	2,027	3,254	3,809	4,773
Net Cash (Debt)	3,411	3,440	2,505	2,230	-304	1,325
Net Cash Growth	11.98%	37.33%	12.33%	-	-	-72.68%
Net Cash Per Share	67.88	68.48	49.92	47.09	-6.97	30.45
Filing Date Shares Outstanding	50.25	50.25	50.19	50.15	43.58	43.58
Total Common Shares Outstanding	50.25	50.25	50.19	49.95	43.58	43.58
Working Capital	5,664	5,924	5,906	6,063	4,763	9,463
Book Value Per Share	164.43	169.49	158.65	134.90	184.57	293.84
Tangible Book Value	8,231	8,483	7,936	6,737	7,821	12,507
Tangible Book Value Per Share	163.80	168.81	158.11	134.88	179.48	286.98

Source: S&P Global Market Intelligence. Standard template. Financial Sources.